HIM
RCUS icon

Hillhouse Investment Management’s Arcus Biosciences RCUS Stock Holding History

Hillhouse Investment Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$2.72M Hold
342,128
– – 0.09% 33
2019
Q1 		$4.27M Hold
342,128
– – 0.18% 31
2018
Q4 		$3.69M Sell
342,128
-425,000
-55% -$4.96M 0.28% 20
2018
Q3 		$10.7M Hold
767,128
– – 0.29% 36
2018
Q2 		$9.39M Buy
767,128
+342,128
+81% +$5.37M 0.16% 41
2018
Q1 		$6.56M Buy
+425,000
New +$7.08M 0.12% 38

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Hillhouse Investment Management's RCUS Position: Q2 2019 in Review

Hillhouse Investment Management held its Arcus Biosciences (RCUS) position steady in Q2 2019 at 342,128 shares worth $2.72M. The position accounts for 0.09% of the portfolio, ranked #33.

Hillhouse Investment Management first reported a position in RCUS in Q1 2018 and has held it in 6 quarters since. The position peaked at $10.7M in Q3 2018. 78 funds tracked by Wall St. Rank hold RCUS as of Q2 2019.

  • Hillhouse Investment Management held 342,128 shares of Arcus Biosciences worth $2.72M as of Q2 2019.
  • Hillhouse Investment Management left its Arcus Biosciences share count unchanged in Q2 2019.
  • Arcus Biosciences made up 0.09% of Hillhouse Investment Management's portfolio in Q2 2019, its #33 holding.
  • Hillhouse Investment Management first reported a position in Arcus Biosciences in Q1 2018 and has held it in 6 quarters since.
  • Hillhouse Investment Management's Arcus Biosciences position peaked at $10.7M in Q3 2018.
  • 78 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2019.

Based on Hillhouse Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.